Been seeing a lot of people ask about Canopy Growth lately, so figured I'd share what's actually going on with this stock. Honestly, it's a pretty rough situation if you look at the numbers.

Canopy used to be the darling of the weed stock boom a few years back. At its peak in 2019, this thing was trading over $560 per share. Wild, right? Fast forward to now and you're looking at a stock trading around a dollar. That's not a dip, that's a complete collapse. We're talking 95% down from the IPO levels. It basically went from Wall Street's favorite play to penny stock territory.

Here's the thing though - companies don't just end up as penny stocks by accident. Canopy has been burning through cash for roughly a decade as a public company and still hasn't managed to post positive earnings. That's a brutal track record. Investors have been patient, but that patience is clearly wearing thin.

What makes it even more interesting is what happened recently. Late last year the company had to recapitalize its balance sheet, which sounds positive on the surface but it's actually a sign of serious financial stress. They basically had to cut deals with bondholders and throw in warrants just to get them to cooperate. If those warrants get exercised, existing shareholders get diluted. Not great.

Meanwhile, they're pushing forward with acquiring MTL Cannabis to strengthen their medical marijuana position. Except here's the problem - they're doing this as a cash and stock deal while they're already in a weak financial position. More dilution coming, more strain on an already stretched balance sheet.

Could this all work out? Maybe. There's a chance Canopy figures things out and becomes sustainably profitable. But there's also a very real risk they're overextending themselves right now. For most investors, the risk-reward just doesn't make sense here. This feels like a situation where the downside is way bigger than the upside, and honestly, there are better opportunities out there if you're looking to deploy capital.